In: Biology
Matching
| 
 1.  | 
 Astrocytes  | 
 A. Sheet-like cancer of epithelial origin  | 
| 
 2.  | 
 Immortality  | 
 B. Can cause senescence in dividing cells  | 
| 
 3.  | 
 Squamous carcinoma  | 
 C. Increases risk of breast cancer  | 
| 
 4.  | 
 Metaplasia (example)  | 
 D. Decreases risk of breast cancer  | 
| 
 5.  | 
 Adenocarcinoma  | 
 E. Associated with stomach cancer incidence patterns  | 
| 
 6.  | 
 Having no natural-born children  | 
 F. Can affect cell shape, cell adhesion, and cell motility  | 
| 
 7.  | 
 Over-expression or mis-expression of a receptor on breast cancer cells  | 
 G. Supporting cells in the brain  | 
| 
 8.  | 
 aneuploidy  | 
 H. Can cross-link receptors in the membrane of a cell  | 
| 
 9.  | 
 Helicobacter pylori infection  | 
 I. Neoplasm brain tissue origin  | 
| 
 10.  | 
 Shortening of telomeres  | 
 J. Neoplasm of striated muscle cell origin  | 
| 
 11.  | 
 Leading cause of cancer deaths in women  | 
 K. Can lead to activation of cancer-causing genes  | 
| 
 12.  | 
 Astrocytoma or glioblastoma  | 
 L. The lymphatic system  | 
| 
 13.  | 
 cytoskeletal anaplasia  | 
 M. Can have early onset multifocal incidence pattern  | 
| 
 14.  | 
 Bilateral retinoblastoma  | 
 N. Phenotypic characteristic of many cancer cells in culture  | 
| 
 15.  | 
 Genomic instability and selection  | 
 O. Hepatitis B Virus  | 
| 
 16.  | 
 Onco-fetal gene products  | 
 P. Sac-like or glandular neoplasm of epithelial cell origin  | 
| 
 17.  | 
 Bivalent growth factors  | 
 Q. Ewing's sarcoma  | 
| 
 18.  | 
 Can lead to hepatocellular carcinoma  | 
 R. Can lead to drug resistance during treatment  | 
| 
 19.  | 
 Genetic drift  | 
 S. Ciliated epithelium replaced by squamous epithelium  | 
| 
 20.  | 
 Lower dietary fat and body mass  | 
 T. Abnormal number and form of chromosomes  | 
| 
 21.  | 
 Rhabdomyosarcoma  | 
 U. Can happen when cell lines are passaged repeatedly  | 
| 
 22.  | 
 Fusion protein gene product  | 
 V. Often re-expressed in cancer cells  | 
| 
 23.  | 
 Protease inhibitors  | 
 W. Target for Herceptin  | 
| 
 24.  | 
 Route of metastatic spread  | 
 X. Lung cancer  | 
| 
 25.  | 
 form of bone cancer  | 
 Y. Might inhibit invasion  | 
| 
 1.  | 
 Astrocytes  | 
 G. Supporting cells in the brain.  | 
| 
 2.  | 
 Immortality  | 
 N. Phenotypic characteristic of many cancer cells in culture  | 
| 
 3.  | 
 Squamous carcinoma  | 
 A. Sheet-like cancer of epithelial origin  | 
| 
 4.  | 
 Metaplasia (example)  | 
 S. Ciliated epithelium replaced by squamous epithelium  | 
| 
 5.  | 
 Adenocarcinoma  | 
 P. Sac-like or glandular neoplasm of epithelial cell origin  | 
| 
 6.  | 
 Having no natural-born children  | 
 C. Increases risk of breast cancer  | 
| 
 7.  | 
 Over-expression or mis-expression of a receptor on breast cancer cells  | 
 W. Target for Herceptin  | 
| 
 8.  | 
 aneuploidy  | 
 T. Abnormal number and form of chromosomes  | 
| 
 9.  | 
 Helicobacter pylori infection  | 
E. Associated with stomach cancer incidence patterns | 
| 
 10.  | 
 Shortening of telomeres  | 
 B. Can cause senescence in dividing cells  | 
| 
 11.  | 
 Leading cause of cancer deaths in women  | 
 X. Lung cancer  | 
| 
 12.  | 
 Astrocytoma or glioblastoma  | 
 I. Neoplasm brain tissue origin  | 
| 
 13.  | 
 cytoskeletal anaplasia  | 
 F. Can affect cell shape, cell adhesion, and cell motility  | 
| 
 14.  | 
 Bilateral retinoblastoma  | 
 M. Can have early onset multifocal incidence pattern  | 
| 
 15.  | 
 Genomic instability and selection  | 
 K. Can lead to activation of cancer-causing genes  | 
| 
 16.  | 
 Onco-fetal gene products  | 
 R. Can lead to drug resistance during treatment  | 
| 
 17.  | 
 Bivalent growth factors  | 
 H. Can cross-link receptors in the membrane of a cell  | 
| 
 18.  | 
 Can lead to hepatocellular carcinoma  | 
 O. Hepatitis B Virus  | 
| 
 19.  | 
 Genetic drift  | 
 U. Can happen when cell lines are passaged repeatedly  | 
| 
 20.  | 
 Lower dietary fat and body mass  | 
 D. Decreases risk of breast cancer  | 
| 
 21.  | 
 Rhabdomyosarcoma  | 
 J. Neoplasm of striated muscle cell origin  | 
| 
 22.  | 
 Fusion protein gene product  | 
 V. Often re-expressed in cancer cells  | 
| 
 23.  | 
 Protease inhibitors  | 
 Y. Might inhibit invasion  | 
| 
 24.  | 
 Route of metastatic spread  | 
 L. The lymphatic system  | 
| 
 25.  | 
 form of bone cancer  | 
 Q. Ewing's sarcoma  |